(Reuters) – The New York Stock Exchange opened up sharply on Monday, the S&P 500 and the NASDAQ affecting records against optimism concerning pricing negotiations and reductions in Fed rates this year.
In the first exchanges, the Dow Jones index earns 195.84 points, or 0.45% to 44,015.11 points, and the Standard & Poor’s 500, wider, increased from 0.32% to 6,192.97 points.
The Nasdaq Composite takes 0.46% or 93.65 points, at 20,367.11 points.
Commercial policy returns to the front of the scene with the approach of the deadline of July 9 set for the conclusion of agreements aimed at dissuading the United States from imposing customs duties raised on its main business partners.
Canada has canceled its digital services (TSN) targeting technological companies, including the Americans, on Sunday evening, in order to advance trade negotiations that Washington had interrupted on Friday due to the entry into force of this measure.
The return of the two neighbors to the negotiating table is applauded by investors eager for progress on the commercial front, who hope to see other agreements materialize in the coming days.
In addition, bets on a recovery in interest rate decreases after a series of low macroeconomic data and the anticipation that the White House could replace the president of the American central bank, Jerome Powell, by a more accommodating manager in monetary policy, are also factors of support for shares.
According to the Fedwatch tool of the CME, the traders estimate at 73.8% the probability of a first drop in Fed rates in September, and 21.2% that of a decrease in July.
This revival of appetite for the risk allowed the S&P 500 reference index and the Nasdaq Composite, with a strong technological component, to reach records last Friday.
Investors, however, look at an concern a possible explosion of the US budget deficit while Donald Trump’s budget bill, which he called “Big Beautiful Bill”, is examined in the Senate.
At the values, Oracle takes 5.9% after having signed a “cloud” service agreement which should contribute to more than $ 30 billion to the annual turnover from the 2028 fiscal year.
Moderna, who said on Monday that her experimental influenza vaccine was 26.6% more efficient than the antigripping vaccine currently authorized, advances by 4.6%.
(Written by Diana Mandiá)
Copyright © 2025 Thomson Reuters
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
